About Dr. Shi Guowei
Dr. Shi Guowei is a senior cardiac surgeon in the Department of Cardiovascular Surgery at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine — one of China's most prestigious and historically significant academic medical centers. With extensive clinical experience in complex cardiac surgery, Dr. Shi has established himself as one of Shanghai's leading specialists in minimally invasive heart valve surgery, coronary artery bypass grafting, and aortic surgery, with a particular reputation for his technical precision in valve repair and his commitment to individualized, patient-centered surgical planning.
Dr. Shi's clinical philosophy centers on a principle that guides his approach to every case: whenever possible, preserve the patient's own tissue. In the context of heart valve disease, this means prioritizing valve repair over valve replacement — a technically more demanding but clinically superior approach that eliminates the need for lifelong anticoagulation, preserves native cardiac geometry, and delivers better long-term heart function. His expertise in minimally invasive techniques — including video-assisted thoracoscopic cardiac surgery through incisions of 4–5 cm — means that patients who come to Ruijin Hospital for valve surgery can expect not only excellent cardiac outcomes but also dramatically shorter recovery times compared to conventional open-heart surgery: hospital stays of 5–7 days rather than 10–14, return to light activity within 2–3 weeks, and full recovery in 6–8 weeks rather than 3–6 months.
For international patients — many of whom have been told by surgeons in their home countries that open-heart surgery with full sternotomy is their only option — Dr. Shi's minimally invasive approach frequently offers a path that is both medically superior and practically feasible: a shorter time away from home, less disruption to work and family life, and a faster return to the activities that matter.
Hospital Affiliation: Department of Cardiovascular Surgery, Ruijin Hospital
Ruijin Hospital (瑞金医院), affiliated with Shanghai Jiao Tong University School of Medicine, is one of Shanghai's oldest and most respected academic medical institutions, founded in 1907 and consistently ranked among China's top hospitals across multiple specialties. Its Department of Cardiovascular Surgery is a high-volume, multidisciplinary cardiac surgery program equipped with state-of-the-art hybrid operating theaters, advanced heart-lung bypass and perfusion technology, a dedicated cardiac ICU with 24-hour specialist coverage, and a fully integrated multidisciplinary heart team comprising cardiac surgeons, interventional cardiologists, cardiac anesthesiologists, perfusionists, cardiac imaging specialists, and cardiac rehabilitation professionals.
The department performs a high volume of cardiac surgical procedures annually, including valve repair and replacement, coronary artery bypass grafting, aortic surgery, congenital heart disease correction in adults, and complex reoperations. Its minimally invasive cardiac surgery program — in which Dr. Shi is a key contributor — is one of the most active in eastern China, offering video-assisted thoracoscopic approaches to mitral, aortic, and tricuspid valve surgery that are not widely available outside major academic centers. The department's cardiac ICU and postoperative care infrastructure are designed to support rapid recovery and early mobilization, and its outcomes data for valve surgery and CABG are consistent with international benchmarks.
For international patients, Ruijin Hospital offers world-class cardiac surgical care at a fraction of the cost of equivalent procedures in Australia, the United Kingdom, the United States, or Canada — with access to specialist consultation, preoperative evaluation, and surgical scheduling typically achievable within days rather than the months-long waiting periods common in public healthcare systems abroad.
Clinical Specialties: What Dr. Shi Guowei Treats
- Minimally invasive mitral valve repair and replacement — video-assisted thoracoscopic surgery (VATS) for mitral regurgitation due to leaflet prolapse, chordal rupture, annular dilatation, or rheumatic disease; annuloplasty ring implantation, leaflet resection, chordae tendineae reconstruction, and artificial chordae implantation; mitral valve replacement with mechanical or biological prostheses when repair is not feasible
- Minimally invasive aortic valve surgery — upper hemisternotomy or right anterior thoracotomy approaches for aortic stenosis and aortic regurgitation; aortic valve repair (cusp augmentation, root remodeling) and replacement; collaboration with the interventional cardiology team for transcatheter aortic valve implantation (TAVI) in high-risk surgical patients
- Tricuspid valve repair — ring annuloplasty for functional tricuspid regurgitation secondary to left-sided valve disease or right heart dilatation; concomitant tricuspid repair during mitral or aortic valve surgery
- Coronary artery bypass grafting (CABG) — on-pump and off-pump CABG for multivessel coronary artery disease; arterial revascularization using internal mammary artery and radial artery conduits; combined valve surgery and CABG for patients with coexisting valve disease and coronary disease
- Aortic root and ascending aorta surgery — Bentall procedure for aortic root aneurysm with aortic regurgitation; valve-sparing aortic root replacement (David procedure) for patients with structurally normal aortic valve leaflets; ascending aorta replacement for isolated ascending aortic aneurysm
- Congenital heart disease in adults — surgical correction of atrial septal defect (ASD), ventricular septal defect (VSD), and other congenital lesions presenting in adulthood; minimally invasive approaches for ASD closure
- Redo cardiac surgery — complex reoperations for patients with prior cardiac surgery requiring valve reoperation, CABG revision, or management of prosthetic valve dysfunction or endocarditis
- Atrial fibrillation surgery — concomitant surgical ablation (Cox-Maze procedure or pulmonary vein isolation) for patients with atrial fibrillation undergoing valve surgery or CABG
Minimally Invasive Cardiac Surgery: The Technical Approach
Conventional open-heart surgery requires a full median sternotomy — the breastbone is divided along its entire length and the chest is spread apart to provide access to the heart. While this approach is effective and remains the standard for many complex cardiac procedures, it carries significant physical trauma: a 20–25 cm incision, division of the sternum, 10–14 days of hospitalization, 6–8 weeks of sternal precautions restricting arm movement and lifting, and 3–6 months before full recovery of physical capacity.
Dr. Shi Guowei's minimally invasive approach replaces the sternotomy with a 4–5 cm incision between the ribs on the right side of the chest, through which a high-definition video camera and specialized surgical instruments are introduced. The heart is accessed via video-assisted thoracoscopic guidance, with the surgeon working from a magnified, real-time view of the cardiac structures on a monitor. Heart-lung bypass is established through peripheral cannulation of the femoral vessels rather than through the chest, eliminating the need for large chest tubes through the sternum.
The technical advantages of this approach for valve surgery are substantial. The magnified thoracoscopic view provides superior visualization of the mitral valve apparatus — leaflets, chordae tendineae, papillary muscles, and annulus — compared to the direct view through a sternotomy, enabling more precise and complete repair. The absence of sternal division eliminates the most painful and recovery-limiting aspect of conventional cardiac surgery. And the smaller wound carries a lower risk of wound infection, mediastinitis, and sternal dehiscence — complications that, while uncommon, can be devastating when they occur after conventional sternotomy.
For international patients, the practical implications are significant: a hospital stay of 5–7 days, return to light activity within 2–3 weeks, and the ability to fly home within 2–3 weeks of surgery — compared to the 6–8 week minimum before air travel that is typically recommended after conventional sternotomy.
Why International Patients Choose Dr. Shi Guowei and Ruijin Hospital
International patients seek consultation with Dr. Shi Guowei and Ruijin Hospital's cardiac surgery program for a range of reasons that reflect both the clinical excellence of the program and the practical advantages of accessing cardiac surgical care in Shanghai.
For patients with mitral valve disease — the most common reason international patients seek Dr. Shi's expertise — the combination of his commitment to valve repair over replacement and his minimally invasive technique offers outcomes that are difficult to match outside a small number of high-volume valve surgery centers worldwide. Mitral valve repair, when performed by an experienced surgeon, is associated with better long-term survival, better preservation of left ventricular function, and freedom from the anticoagulation requirements and prosthesis-related complications of mechanical valve replacement. The minimally invasive approach adds the practical benefits of faster recovery and shorter hospitalization without compromising the quality of the repair.
For patients who have been told that their valve disease requires open-heart surgery with full sternotomy, a consultation with Dr. Shi frequently reveals that a minimally invasive approach is feasible — a finding that can transform the patient's experience of surgery and recovery. For patients who have been told that their valve is not repairable and requires replacement, Dr. Shi's assessment may identify repair options that were not apparent to surgeons with less specialized valve surgery experience.
For patients with coronary artery disease requiring bypass surgery, or aortic disease requiring root or ascending aorta surgery, Ruijin Hospital's cardiac surgery program offers high-volume experience, excellent outcomes data, and access to the full range of surgical techniques — including off-pump CABG and valve-sparing aortic root replacement — at costs substantially below those of equivalent procedures in Western healthcare systems.
The speed of access to care at Ruijin Hospital is a further practical advantage for international patients. Specialist consultation, preoperative evaluation (echocardiography, coronary angiography, CT angiography, pulmonary function testing), and surgical scheduling can typically be arranged within days of initial contact through CMCS — in contrast to the weeks or months of waiting that are common in public healthcare systems in Australia, the UK, Canada, and many European countries.
What to Expect at Your Consultation
Consultations with Dr. Shi Guowei at Ruijin Hospital arranged through CMCS begin with a comprehensive review of all prior cardiac imaging and investigation — including transthoracic and transesophageal echocardiography reports and images, coronary angiography or CT coronary angiography, cardiac CT or MRI, chest X-ray, ECG, and relevant laboratory results including full blood count, renal and liver function, coagulation studies, and cardiac biomarkers — as well as the patient's cardiac history, symptom timeline, prior cardiac interventions, current medications, and relevant comorbidities. CMCS will arrange certified translation of all medical records, imaging reports, and investigation results in advance of the consultation.
Dr. Shi will assess the nature and severity of the cardiac lesion, evaluate surgical risk using validated risk scoring tools, outline the recommended surgical approach — including the feasibility of minimally invasive technique and the likelihood of valve repair versus replacement — with detailed rationale, and provide a realistic assessment of expected outcomes and recovery timeline. Where appropriate, a multidisciplinary review involving interventional cardiology, cardiac anesthesiology, and cardiac imaging will be coordinated. A written English-language consultation summary is provided after every appointment, and CMCS will facilitate direct communication between Dr. Shi's team and the patient's home cardiologist or cardiac surgeon for continuity of care planning.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides comprehensive end-to-end support for international patients seeking cardiac surgery consultation with Dr. Shi Guowei at Ruijin Hospital. Our services include priority consultation scheduling with Dr. Shi and the cardiovascular surgery team, certified medical record and echocardiography report translation, pre-consultation cardiac imaging review by our clinical coordinators, surgical logistics and hospital admission coordination, visa and travel support, accommodation recommendations near Ruijin Hospital, on-site interpretation throughout the consultation and surgical admission, pharmacy and perioperative medication coordination, and ongoing follow-up coordination between Ruijin Hospital's cardiac surgery team and the patient's home cardiologist after return.
📧 contract@medicalsh.com | 💬 WeChat: gezhanglao | 🌐 medicalsh.com
0 commentaire